A Phase II Study Evaluating the Effect of GEN-1 on SLL When Administered in Combination With Bevacizumab and NACT in Subjects Newly Diagnosed With Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer Interventions: Drug: Paclitaxel; Drug: Carboplatin; Drug: Bevacizumab; Drug: GEN1 Sponsors: Imunon; Break Through Cancer Foundation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Fallopian Tube Cancer | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research | Study